研究发现,像Wegovy这样的肥胖药物在一半的社会饮酒者中减少了酒精消费量。 Study finds obesity drugs like Wegovy reduce alcohol consumption in half of social drinkers.

JAMA Network Open杂志最近的一项研究发现,大约一半服用肥胖药物(如Wegovy或Mounjaro)的社会饮酒者报告酒精消费量有所下降。 A recent study in the journal JAMA Network Open found that about half of social drinkers taking obesity medications like Wegovy or Mounjaro reported a decrease in alcohol consumption. 这项研究调查了近14 000名体重观察员成员。 The study surveyed nearly 14,000 Weight Watchers members. 研究人员指出,这些药物可能会影响大脑的奖励制度,减少对酒精的渴望,并有可能协助戒毒治疗。 Researchers suggest that these medications may impact the brain's reward system, reducing the desire for alcohol and potentially aiding in addiction treatment.